Press Release
06/10/2026 Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care ModelWould you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.
You can cancel this free service at any time by sending an e-mail to
ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.
The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.
Filter by:
Press Release
06/10/2026 Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care ModelInsights
06/10/2026 High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in DialysisPress Release
06/03/2026 Ģý launches kinexus worldwide, a unified digital platform to support home dialysisPress Release
05/28/2026 Ģý launches first tranche of its share buyback program of up to EUR 600 millionPress Release
05/26/2026 Ģý announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 monthsPress release
05/21/2026 Ģý Annual General Meeting: Strengthening performance and advancing innovation in kidney carePress release
05/05/2026 Ģý delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speedPress Release
02/24/2026 Ģý delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target bandPress Release
01/09/2026 Ģý accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase plannedPress Release
12/10/2025 Ģý appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management BoardPress release
11/04/2025 Ģý further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025Press Release
10/30/2025 Ģý highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025Press Release
09/18/2025 Ģý advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segmentPress Release
08/11/2025 Ģý announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation frameworkPress release
08/05/2025 Ģý delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025Press Release
07/31/2025 ĢýĢýs Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease CarePress Release
07/03/2025 Ģý Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in MexicoPress Release
06/17/2025 Ģý Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value CreationPress Release
06/04/2025 Ģý Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.Press Release
05/30/2025 New research and innovation for kidney care at European Renal Association Congress 2025Press Release
05/22/2025 Ģý Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its HistoryPress release
03/28/2025 Ģý Expands Production of bibag® Dry Bicarbonate Concentrate Bags for Hemodialysis in the State of São Paulo in BrazilPress Release
03/13/2025 Ģý publishes its joint Annual Report and Sustainability Statement for 2024: Building the MomentumPress Release
02/25/2025 Ģý delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025Media Statement
01/10/2025 Ģý Supports Patients and Staff During the Wildfires in Southern CaliforniaPress Release
12/22/2024 Ģý Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe IndexShort News
12/15/2024 Ģý has been ranked #1 on the Gender Diversity Index Germany by the Boston Consulting GroupPress release
11/19/2024 Ģý Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO SystemPress release
11/18/2024 ĢýĢýs AI-Powered Application of the Anemia Control Model Selected for CMS AI Demo Days in the United StatesShort News
11/13/2024 Ģý launches the "Living Well" campaign on World Diabetes Day to raise awareness for patients living with diabetes, which is one of the leading causes of chronic kidney diseasePress release
11/05/2024 Ģý reports strong operating income margin growth in the third quarter of 2024Short News
11/01/2024 Ģý and CEO Helen Giza Ranked Among Top 100 Women-Led Businesses in MassachusettsPress release
10/24/2024 Ģý Recent Study Validates Innovative Anemia Therapy Software Improves Clinical Outcomes for Hemodialysis PatientsMedia Statement
10/21/2024 Ģý Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024Media Statement
10/15/2024 All Ģý dialysis clinics are open and fully operational in the regions affected by Hurricane Milton and Hurricane HeleneMedia Statement
10/10/2024 Ģý ramping up supply of IV fluids and PD products post-Hurricane Helene and is ensuring safety of patients and employees in the face of Hurricane MiltonPress Release
09/04/2024 Ģý Grows Number of U.S. Patients Using CompanyĢýs Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe SoftwarePress Release
07/30/2024 Ģý delivers continued operating income improvements in the second quarter of 2024Press Release
06/12/2024 Ģý takes next important step towards goal to reduce CO2 emissions in its operationsPress Release
05/28/2024 Liberty Dialysis Opens First Patient Training Center for Home Hemodialysis in Windward OĢýahuPress Release
05/21/2024 Ģý showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024Press Release
05/16/2024 Ģý Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth TargetsPress Release
03/22/2024 Ģý publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney CarePress Release
03/19/2024 Ģý launches ĢýAugmented RealityĢý for training on Kidney Replacement Therapy devicePress Release
03/13/2024 Ģý appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human ResourcesPress Release
03/05/2024 Ģý Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, EcuadorPress Release
02/08/2024 Ģý Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering TechnologiesPress Release
01/08/2024 Ģý Executes on Its Strategic Portfolio Optimization Program and Announces Key TransactionsPress Release
11/21/2023 Ģý enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million Ģý 2023 earnings outlook raisedPress Release
11/01/2023 Ģý continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarterPress Release
10/31/2023 Ģý Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023Press Release
10/26/2023 Ģý Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical DatasetPress Release
07/31/2023 Ģý successfully executes strategic plan and narrows guidance range due to strong operational performance in the first half of 2023Press Release
07/14/2023 Ģý simplifies corporate structure by converting into a German stock corporationPress Release
06/20/2023 Breakthrough Study Demonstrates that High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality RatesPress Release
06/05/2023 Ģý proposes candidates for election to the new Supervisory Board after conversionPress Release
05/16/2023 Annual General Meeting of Ģý: Company on clearly defined path to transformational turnaround and to further unlocking value as leading kidney care companyPress Release
05/09/2023 Ģý sees improving trends in the first quarter and is progressing on its transformationPress Release
04/12/2023 Ģý underlines commitment towards gender equity in the workplace, signing United Nations WomenĢýs Empowerment PrinciplesPress Release
02/21/2023 Ģý proposes to its shareholders to change its legal form to simplify the governance structure and strengthen shareholder rightsPress release
02/20/2023 Ģý delivers against FY22 expectations, sets strategic focus and accelerates transformationPress release
01/19/2023 Ģý takes action to close global health gaps, signs ĢýZero Health GapsĢý Pledge at the World Economic ForumRelated content
Do you have any questions? Contact us!
Ģý Ģý THE RENAL COMPANY is the worldĢýs leading provider of dialysis products and services. Find out more about the companyĢýs history.
Investors
Healthcare Professionals
Legal and regulatory
© Ģý AG 2026